Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Leick

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Cytometry. Part B, Clinical Cytometry|February 28, 2024
Optimization of a flow cytometry test for routine monitoring of B cell maturation antigen targeted CAR in peripheral bloodWon-Ho Lee, Charlotte E Graham, Hadley R Wiggin, et al.
Cell Chemical Biology|November 21, 2023
Genetic retargeting of E3 ligases to enhance CAR T cell therapyIsabel C Lane, Gabriele Kembuan, Jeannie Carreiro, et al.
Blood|November 21, 2024
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AMLHarrison J Silva, Grace Martin, Filippo Birocchi, et al.
Journal for Immunotherapy of Cancer|September 10, 2025
Tandem CAR-T cells targeting mesothelin and MUC16 overcome tumor heterogeneity by targeting one antigen at a timeDiego Salas-Benito, Filippo Birocchi, Sangwoo Park, et al.
Blood|July 19, 2023
Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicityCharlotte E Graham, Won-Ho Lee, Hadley R Wiggin, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastomaBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Journal for Immunotherapy of Cancer|September 9, 2020
Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sourcesAndrea Schmidts, Leah C Marsh, Ambike A Srivastava, et al.
Nature|April 14, 2022
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumoursRebecca C Larson, Michael C Kann, Stefanie R Bailey, et al.
Nature Biotechnology|July 24, 2019
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicityBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Cancer Immunology Research|June 2, 2025
Secretion of a VEGF-Blocking scFv Enhances CAR T-cell PotencyValentina M Supper, Hannah Donner, Filippo Birocchi, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cytometry. Part B, Clinical Cytometry|February 28, 2024
Optimization of a flow cytometry test for routine monitoring of B cell maturation antigen targeted CAR in peripheral bloodWon-Ho Lee, Charlotte E Graham, Hadley R Wiggin, et al.
Cell Chemical Biology|November 21, 2023
Genetic retargeting of E3 ligases to enhance CAR T cell therapyIsabel C Lane, Gabriele Kembuan, Jeannie Carreiro, et al.
Blood|November 21, 2024
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AMLHarrison J Silva, Grace Martin, Filippo Birocchi, et al.
Journal for Immunotherapy of Cancer|September 10, 2025
Tandem CAR-T cells targeting mesothelin and MUC16 overcome tumor heterogeneity by targeting one antigen at a timeDiego Salas-Benito, Filippo Birocchi, Sangwoo Park, et al.
Blood|July 19, 2023
Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicityCharlotte E Graham, Won-Ho Lee, Hadley R Wiggin, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastomaBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Journal for Immunotherapy of Cancer|September 9, 2020
Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sourcesAndrea Schmidts, Leah C Marsh, Ambike A Srivastava, et al.
Nature|April 14, 2022
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumoursRebecca C Larson, Michael C Kann, Stefanie R Bailey, et al.
Nature Biotechnology|July 24, 2019
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicityBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Cancer Immunology Research|June 2, 2025
Secretion of a VEGF-Blocking scFv Enhances CAR T-cell PotencyValentina M Supper, Hannah Donner, Filippo Birocchi, et al.
Pageof 6